Literature DB >> 24704100

EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population.

Kenya Nishioka1, Manabu Funayama2, Carles Vilariño-Güell3, Kotaro Ogaki1, Yuanzhe Li4, Ryogen Sasaki5, Yasumasa Kokubo5, Shigeki Kuzuhara6, Jennifer M Kachergus7, Stephanie A Cobb7, Hirohide Takahashi8, Yoshikuni Mizuno4, Matthew J Farrer3, Owen A Ross9, Nobutaka Hattori4.   

Abstract

Pathogenic mutations in the EIF4G1 gene were recently reported as a cause of autosomal dominant parkinsonism. To assess the frequency of EIF4G1 mutations in the Japanese population we sequenced the entire gene coding region (31 exons) in 95 patients with an apparent autosomal dominant inherited form of Parkinson's disease. We detected three novel point mutations located in a poly-glutamic acid repeat within exon 10. These variants were screened through 224 Parkinson's disease cases and 374 normal controls from the Japanese population. We detected the poly-glutamic acid deletion in exon 10 in two additional patients with sporadic Parkinson's disease. Although the EIF4G1 variants identified in the present study were not observed in control subjects, co-segregation analyses and population-based screening data suggest they are not pathogenic. In conclusion, we did not identify novel or previously reported pathogenic mutations (including the p.A502V and p.R1205H mutants) within EIF4G1 in the Japanese population, thus future studies are warranted to elucidate the role of this gene in Parkinson's disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EIF4G1; Genetics; Mutation; Parkinson's disease

Mesh:

Substances:

Year:  2014        PMID: 24704100      PMCID: PMC4034257          DOI: 10.1016/j.parkreldis.2014.03.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  22 in total

Review 1.  Autosomal recessive parkinsonism.

Authors:  Vincenzo Bonifati
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  Role of mendelian genes in "sporadic" Parkinson's disease.

Authors:  Suzanne Lesage; Alexis Brice
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 3.  Synucleinopathies from bench to bedside.

Authors:  Andreas Puschmann; Roongroj Bhidayasiri; William J Weiner
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

4.  Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Authors:  Owen A Ross; Alexandra I Soto-Ortolaza; Michael G Heckman; Jan O Aasly; Nadine Abahuni; Grazia Annesi; Justin A Bacon; Soraya Bardien; Maria Bozi; Alexis Brice; Laura Brighina; Christine Van Broeckhoven; Jonathan Carr; Marie-Christine Chartier-Harlin; Efthimios Dardiotis; Dennis W Dickson; Nancy N Diehl; Alexis Elbaz; Carlo Ferrarese; Alessandro Ferraris; Brian Fiske; J Mark Gibson; Rachel Gibson; Georgios M Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasinska-Myga; Beom S Jeon; Yun Joong Kim; Christine Klein; Rejko Kruger; Elli Kyratzi; Suzanne Lesage; Chin-Hsien Lin; Timothy Lynch; Demetrius M Maraganore; George D Mellick; Eugénie Mutez; Christer Nilsson; Grzegorz Opala; Sung Sup Park; Andreas Puschmann; Aldo Quattrone; Manu Sharma; Peter A Silburn; Young Ho Sohn; Leonidas Stefanis; Vera Tadic; Jessie Theuns; Hiroyuki Tomiyama; Ryan J Uitti; Enza Maria Valente; Simone van de Loo; Demetrios K Vassilatis; Carles Vilariño-Güell; Linda R White; Karin Wirdefeldt; Zbigniew K Wszolek; Ruey-Meei Wu; Matthew J Farrer
Journal:  Lancet Neurol       Date:  2011-08-30       Impact factor: 44.182

5.  Translation initiator EIF4G1 mutations in familial Parkinson disease.

Authors:  Marie-Christine Chartier-Harlin; Justus C Dachsel; Carles Vilariño-Güell; Sarah J Lincoln; Frédéric Leprêtre; Mary M Hulihan; Jennifer Kachergus; Austen J Milnerwood; Lucia Tapia; Mee-Sook Song; Emilie Le Rhun; Eugénie Mutez; Lydie Larvor; Aurélie Duflot; Christel Vanbesien-Mailliot; Alexandre Kreisler; Owen A Ross; Kenya Nishioka; Alexandra I Soto-Ortolaza; Stephanie A Cobb; Heather L Melrose; Bahareh Behrouz; Brett H Keeling; Justin A Bacon; Emna Hentati; Lindsey Williams; Akiko Yanagiya; Nahum Sonenberg; Paul J Lockhart; Abba C Zubair; Ryan J Uitti; Jan O Aasly; Anna Krygowska-Wajs; Grzegorz Opala; Zbigniew K Wszolek; Roberta Frigerio; Demetrius M Maraganore; David Gosal; Tim Lynch; Michael Hutchinson; Anna Rita Bentivoglio; Enza Maria Valente; William C Nichols; Nathan Pankratz; Tatiana Foroud; Rachel A Gibson; Faycal Hentati; Dennis W Dickson; Alain Destée; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

6.  PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy.

Authors:  Sumihiro Kawajiri; Shinji Saiki; Shigeto Sato; Fumiaki Sato; Taku Hatano; Hiroto Eguchi; Nobutaka Hattori
Journal:  FEBS Lett       Date:  2010-02-12       Impact factor: 4.124

7.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

8.  EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa.

Authors:  Janine Blanckenberg; Claudia Ntsapi; Jonathan A Carr; Soraya Bardien
Journal:  Neurobiol Aging       Date:  2013-09-27       Impact factor: 4.673

9.  Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer.

Authors:  Deborah Silvera; Rezina Arju; Farbod Darvishian; Paul H Levine; Ladan Zolfaghari; Judith Goldberg; Tsivia Hochman; Silvia C Formenti; Robert J Schneider
Journal:  Nat Cell Biol       Date:  2009-06-14       Impact factor: 28.824

10.  eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy.

Authors:  Francisco Ramírez-Valle; Steve Braunstein; Jiri Zavadil; Silvia C Formenti; Robert J Schneider
Journal:  J Cell Biol       Date:  2008-04-21       Impact factor: 10.539

View more
  6 in total

1.  EIF4G1 mutations do not cause Parkinson's disease.

Authors:  Noah Nichols; Jose M Bras; Dena G Hernandez; Iris E Jansen; Suzanne Lesage; Steven Lubbe; Andrew B Singleton
Journal:  Neurobiol Aging       Date:  2015-05-09       Impact factor: 4.673

2.  Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

Authors:  Prabhjyot Saini; Uladzislau Rudakou; Eric Yu; Jennifer A Ruskey; Farnaz Asayesh; Sandra B Laurent; Dan Spiegelman; Stanley Fahn; Cheryl Waters; Oury Monchi; Yves Dauvilliers; Nicolas Dupré; Lior Greenbaum; Sharon Hassin-Baer; Alberto J Espay; Guy A Rouleau; Roy N Alcalay; Edward A Fon; Ronald B Postuma; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2020-10-31       Impact factor: 4.673

3.  Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein.

Authors:  Nripesh Dhungel; Simona Eleuteri; Ling-Bo Li; Nicholas J Kramer; Justin W Chartron; Brian Spencer; Kori Kosberg; Jerel Adam Fields; Klodjan Stafa; Anthony Adame; Hilal Lashuel; Judith Frydman; Kang Shen; Eliezer Masliah; Aaron D Gitler
Journal:  Neuron       Date:  2014-12-18       Impact factor: 17.173

Review 4.  Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease.

Authors:  Zhi Dong Zhou; Thevapriya Selvaratnam; Ji Chao Tristan Lee; Yin Xia Chao; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2019-02-04       Impact factor: 8.014

Review 5.  Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies.

Authors:  Kenya Nishioka; Yuzuru Imai; Hiroyo Yoshino; Yuanzhe Li; Manabu Funayama; Nobutaka Hattori
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

6.  Commentary: Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein.

Authors:  Diana A Olszewska; Allan McCarthy; Tim Lynch
Journal:  Front Neurosci       Date:  2016-04-18       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.